Szklener, K. et al. 2022. Unexpectedly long progression-free time in a patient with squamous cell carcinoma of the lung treated with Nivolumab – a case study. Journal of Education, Health and Sport. 12, 8 (Aug. 2022), 509–517. DOI:https://doi.org/10.12775/JEHS.2022.12.08.053.